Dejuan L. Owens serves as the Associate Director of Supply Chain at ReCode Therapeutics, where he plays a pivotal role in advancing the company’s mission to innovate in the biotechnology sector, particularly in the development of mRNA therapies and lipid nanoparticles. With a robust background...
Dejuan L. Owens serves as the Associate Director of Supply Chain at ReCode Therapeutics, where he plays a pivotal role in advancing the company’s mission to innovate in the biotechnology sector, particularly in the development of mRNA therapies and lipid nanoparticles. With a robust background in supply chain management, Dejuan leverages his extensive expertise in medical devices and biotechnology to streamline operations and enhance efficiency across the supply chain. His leadership in CMC (Chemistry, Manufacturing, and Controls) Supply Operations is instrumental in ensuring that clinical supplies are managed effectively, adhering to stringent quality assurance protocols and ISO standards.
At ReCode Therapeutics, Dejuan is currently spearheading key projects that focus on the implementation of advanced ERP systems, which are critical for optimizing inventory management and improving overall supply chain visibility. His commitment to continuous improvement is evident in his application of Lean Manufacturing principles and Six Sigma methodologies, which drive process enhancements and operational excellence. By conducting thorough root cause analyses, he identifies inefficiencies and implements strategic solutions that bolster productivity and reduce costs.
Dejuan’s proficiency in supply management and materials management not only supports the company’s clinical supply needs but also positions ReCode Therapeutics for scalable growth in a competitive landscape. His collaborative approach fosters strong relationships with cross-functional teams, ensuring alignment between supply chain operations and the broader organizational goals. As a certified APICS CPIM professional, Dejuan is dedicated to cultivating a culture of excellence within the supply chain, ultimately contributing to the successful delivery of innovative therapeutics that have the potential to transform patient care.
